methylprednisolone and Leishmaniasis, Mucocutaneous

methylprednisolone has been researched along with Leishmaniasis, Mucocutaneous in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bardelli, M; Garcia-Gonzalez, E; Guidelli, GM; Maggio, R	1

Other Studies

1 other study(ies) available for methylprednisolone and Leishmaniasis, Mucocutaneous

Article	Year
Mucocutaneous leishmaniasis in a patient treated with anti-TNF-α therapy. Rheumatology (Oxford, England), 2012, Volume: 51, Issue:8 Topics: Adalimumab; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Biopsy; Blotting, Western; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique, Indirect; Humans; Leishmania infantum; Leishmaniasis, Mucocutaneous; Male; Methotrexate; Methylprednisolone; Middle Aged; Opportunistic Infections; Spondylitis, Ankylosing; Tomography, X-Ray Computed	2012

Article

Year

Mucocutaneous leishmaniasis in a patient treated with anti-TNF-α therapy.

Rheumatology (Oxford, England), 2012, Volume: 51, Issue:8

Topics: Adalimumab; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Biopsy; Blotting, Western; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique, Indirect; Humans; Leishmania infantum; Leishmaniasis, Mucocutaneous; Male; Methotrexate; Methylprednisolone; Middle Aged; Opportunistic Infections; Spondylitis, Ankylosing; Tomography, X-Ray Computed

2012